To the Editor.
—It was with great interest that I read the editorial by Goldberg1 in the July Archives on the use of antifibrinolytic agents in the treatment of hyphema. Through the efforts of Dr Goldberg and the staff at the University of Illinois Eye and Ear Infirmary, Chicago, the ophthalmological community has become better informed as to the natural course and treatment of traumatic hyphema.2-5 However, as yet unpublished data has recently been compiled in a retrospective fashion on 400 consecutive patients with hyphema. Soma interesting points that differ from previously published data have been found.This study involved all nonperforating hyphemas treated at the Eye Clinic of Wausau, Wausau, Wis (seven ophthalmologists), the Gunderson
Witteman GJ. Traumatic Hyphema. Arch Ophthalmol. 1984;102(3):356–357. doi:10.1001/archopht.1984.01040030276013
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: